Wendy K. Galbraith

Contact Information:
Wendy K. Galbraith



 

Galbraith, Wendy K. (HSC)
Clinical Assistant Professor

Department of:

College Of Pharmacy/Pharmaceutical Sciences -Clinical Assistant Professor

Center of:

Education:

University of Oklahoma Health Sciences Center, OKC   Pharm.D.   2003

Professional Interest/Expertise/Specializations:
Enhancing the education and training experience required by the Nuclear Regulatory Commission (NRC) and the State Board of Oklahoma to be an Authorized Nuclear Pharmacist or an "authorized user" (AU) of radioactive materials. Defining scope of practice, competency standards, and performance improvement parameters for nuclear pharmacists. Improve and expand patient services of the OUHSC Nuclear Pharmacy to clinical areas to promote clinical research and advancement in nuclear medicine. Clinical Expertise: Nuclear Pharmacy and Radiopharmaceuticals. Development and growth of professional education in nuclear pharmacy. This includes overseeing all professional education in nuclear pharmacy including elective/selective course work in the doctor of pharmacy program (including Pharm.D./M.S.), pharmacy interns employed in the nuclear pharmacy, continuing professional education for nuclear pharmacists, board certification for nuclear pharmacists employed in the nuclear pharmacy, residency program in nuclear pharmacy, and nuclear pharmacy education for other health care professionals including but not limited to nuclear medicine technologists, nuclear medicine and radiology residents, and health physicists.

Websites:

Galbraith OUHSC web profile

Research Projects:

A Radiopharmaceutical Kit for PET Renography, Agency: OCAST (HR13-210), 09/01/13-08/31/15

Selected Publications:

Synthesis and in vivo Evaluation of Gallium-68 Labeled Glycine and Hippurate Conjugates for PET Renography.
2015    Pathuri G, Hedrick AF, January S, Galbraith W, Awasthi V, Arnold CD, Cowley BD, Gali H.
J Labeled Compd Radiopharm
Assessment of Technetium-99m Succimer Residual Activity Reduction Using Inert Non-reactive Syringes
2014    Galbraith W, Chen K, Talley K, Grantham V.
J Nucl Med Tech
Assessing the stability of common radiopharmaceuticals compounded and utilized outside package insert guidelines
2013    Weatherman KD, Augustine S, Christoff J, Galbraith WK
Int J Pharm Compounding.
Evaluation of 99mTc-succimer Dosing in Pediatric Patients
2013    Galbraith W, Nguyen A, Harrison DL, Chen X, Talley K.
J Nucl Med Tech
Compounding and Dispensing Errors: Before and After Implementing Barcode Technology in a Nuclear Pharmacy
2012    Galbraith WK, Shadid J
J Intnl Pharm Compound
Radiopharmaceuticals in nuclear medicine.
2010    Galbraith W.
Smith, B ed. Nuclear Pharmacy. London: Pharmaceutical Press; 111-182
Establishing a threshold for [131]I bioassay in nuclear medicine personnel.
2008    Lian Y, Chu RY, Galbraith WK, MacDurmon GW, Sonnad JR.
Operational Radiation Safety (ORS)
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commercial Nuclear Pharmacy Settings
   Weatherman KD, Augustine S, Christoff J, Galbraith WK
Int J Pharm Compounding.
Evaluation of 99mTc-succimer dosing in pediatric patients
   Galbraith WK, Nguyen A, Harrison DL, Chen X, Talley K
J Nucl Med Tech
"Production of Radiopharmaceuticals."
   Galbraith WK
American Society of Nurclear Cardiology Board Preparation Course; San Diego.
Establishing a threshold for [131]i bioassay in nuclear medicine personnel.
   Liang Y, Chu RY, Galbraith WK, MacDurmon GW, Sonnad JR.
Radiation Safety Journal; 95 (suppl 5): S175-S179
Establishing a threshold for [131]i bioassay in nuclear medicine personnel.
   Liang Y, Chu RY, Galbraith WK, MacDurmon GW, Sonnad JR.
Radiation Safety Journal 2008; 95 (suppl 5): S175-S179
Magnetically-targeted technetium 99m-labeled nanoparticles to the inner ear.
   Dormer KJ, Awasthi V, Galbraith W, Kopke RD, Chen K, Wassel R.
J Biomed Nanotechnology 2008; 4(2):174-184(11)
Magnetically-targeted technetium 99m-labeled nanoparticles to the inner ear.
   Dormer KJ, Awasthi V, Galbraith W, Kopke RD, Chen K, Wassel R.
J Biomed Nanotechnology 4(2): 174-184
Interventional agents used in nuclear medicine. In:
   Galbraith W.
Smith, B ed. Nuclear Pharmacy. London: Pharmaceutical Press; 205-223